Skip to main content
Apeloa Pharmaceutical Co.,Ltd. logo

Apeloa Pharmaceutical Co.,Ltd. — Investor Relations & Filings

Ticker · 000739 ISIN · CNE000000Q45 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,843 across all filing types
Latest filing 2017-05-26 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000739

About Apeloa Pharmaceutical Co.,Ltd.

https://www.apeloa.com

Apeloa Pharmaceutical Co., Ltd. focuses on the research, development, manufacturing, and distribution of active pharmaceutical ingredients (APIs), intermediates, and finished dosage forms. The company operates three core business pillars: API production, Contract Development and Manufacturing Organization (CDMO) services, and finished drug products. Its therapeutic focus includes cardiovascular, anti-infective, anti-viral, and oncology treatments. Apeloa utilizes an integrated supply chain to deliver chemical and biological solutions to a global client base. The organization maintains compliance with international quality standards, including certifications from the FDA, EMA, and PMDA. Its CDMO services encompass the full product lifecycle, from process chemistry and analytical development to large-scale commercial manufacturing, supported by specialized technology platforms such as continuous flow chemistry and enzymatic synthesis.

Recent filings

Filing Released Lang Actions
独立董事的独立意见
Regulatory Filings Classification · 95% confidence The document is an independent directors' opinion on a related party transaction, referencing compliance with company law, securities law, and company articles. It is a formal statement of independent directors' views on a specific board meeting agenda item, not a full report or financial statement. The document length is short (583 characters), and it does not contain financial data or detailed financial analysis. It is not an announcement of voting results or a proxy solicitation. This type of document fits best under Regulatory Filings (RNS), as it is a governance-related disclosure but does not fit other more specific categories.
2017-05-26 Chinese
2016年年度报告（更新后）
Annual Report Classification · 100% confidence The document is titled "普洛药业股份有限公司 2016 年年度报告" which translates to "Apeloa Pharmaceutical Co., Ltd. 2016 Annual Report." It contains detailed financial data, business overview, management discussion and analysis, financial statements, and other comprehensive information typical of an annual report. The document length is 15,000 characters, indicating a full report rather than a brief announcement. It includes sections such as company overview, financial indicators, business summary, management discussion and analysis, and financial statements, which are all characteristic of an official yearly report covering company activity and full financial performance. Therefore, this document fits the definition of an Annual Report (10-K). FY 2016
2017-05-19 Chinese
关于2016年年度报告补充说明的公告
Annual Report Classification · 95% confidence The document is titled as a supplementary disclosure announcement related to the company's 2016 Annual Report. It references the original 2016 Annual Report published on March 14, 2017, and provides additional detailed information on various sections such as business overview, investment status, related party transactions, and shareholding changes. The document explicitly states it is a supplement to the 2016 Annual Report and mentions that the updated full 2016 Annual Report will be disclosed simultaneously on the information disclosure platform. The document length is 8674 characters, which is substantial and contains detailed financial and operational data, not just a brief announcement or certification. Therefore, this document is not merely an announcement of the report but a supplementary disclosure to the Annual Report itself. Given the content and context, the filing type best fits the Annual Report (10-K) category, as it supplements and elaborates on the official yearly report covering company activity and financial performance. FY 2016
2017-05-19 Chinese
关于控股股东增持本公司股份的公告
Major Shareholding Notification Classification · 100% confidence The document is a public announcement regarding the increase in shareholding by the controlling shareholder of the company. It details the number of shares purchased, the percentage of total shares, and the purpose of the purchase. There is no financial report, earnings data, or management discussion. The document is about a change in major shareholding levels, which fits the definition of a Major Shareholding Notification (MRQ). The document length is short and focused solely on shareholding changes, confirming it is not a full report or announcement of a report publication.
2017-05-14 Chinese
2016年度股东大会的法律意见书
AGM Information Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the 2016 Annual General Meeting (AGM) of 普洛药业股份有限公司. It details the procedures for convening and holding the AGM, the qualifications of attendees, the agenda items discussed, and the voting procedures. It does not contain the actual AGM materials or presentations but rather a legal opinion on the legitimacy and compliance of the AGM process. The document length is 3721 characters, which is relatively short and consistent with a legal opinion letter rather than a full report or presentation. Therefore, this document fits the category of AGM Information (AGM-R), as it relates to materials shared or opinions given about the AGM proceedings.
2017-04-25 Chinese
第七届董事会第一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the first meeting of the seventh board of directors of 普洛药业股份有限公司, including election and appointment of board members and senior management. It contains detailed voting results and biographies of the appointed individuals. There is no financial data or report content, but rather it is an official disclosure of board and management changes. This fits the category of Board/Management Information (MANG). The document length is 4633 characters, which is sufficient for a detailed announcement but not a full financial report. Therefore, the classification is MANG with high confidence.
2017-04-25 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.